BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18256789)

  • 1. Nasal NK/T-cell lymphoma: epidemiology and pathogenesis.
    Aozasa K; Takakuwa T; Hongyo T; Yang WI
    Int J Hematol; 2008 Mar; 87(2):110-117. PubMed ID: 18256789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and pathogenesis of nasal NK/T-cell lymphoma: a mini-review.
    Aozasa K; Zaki MA
    ScientificWorldJournal; 2011 Feb; 11():422-8. PubMed ID: 21336457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan.
    Takahara M; Kishibe K; Bandoh N; Nonaka S; Harabuchi Y
    Hum Pathol; 2004 Jan; 35(1):86-95. PubMed ID: 14745729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-positive blastoid nasal T/natural killer-cell lymphoma in a caucasian.
    Ling TC; Harris M; Craven NM
    Br J Dermatol; 2002 Apr; 146(4):700-3. PubMed ID: 11966709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
    Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
    Chiang AK; Chan AC; Srivastava G; Ho FC
    Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
    Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
    Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of nasal T/NK-cell lymphoma among Brazilians.
    Altemani A; Barbosa AC; Kulka M; Takahashi T; Endo L; Vassallo J; Lorand-Metze I
    Neoplasma; 2002; 49(1):55-60. PubMed ID: 12044062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.
    Lima M
    Orphanet J Rare Dis; 2013 Jul; 8():95. PubMed ID: 23816348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK/T cell lymphoma in northeast district of China.
    Hoshida Y; Hongyo T; Jia X; He Y; Hasui K; Dong Z; Luo WJ; Ham MF; Nomura T; Aozasa K
    Cancer Sci; 2003 Mar; 94(3):297-301. PubMed ID: 12824925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection.
    Nagata H; Numata T; Konno A; Mikata I; Kurasawa K; Hara S; Nishimura M; Yamamoto K; Shimizu N
    Pathol Int; 2001 Oct; 51(10):778-85. PubMed ID: 11881730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
    Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
    Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-style and environmental factors in the development of nasal NK/T-cell lymphoma: a case-control study in East Asia.
    Xu JX; Hoshida Y; Yang WI; Inohara H; Kubo T; Kim GE; Yoon JH; Kojya S; Bandoh N; Harabuchi Y; Tsutsumi K; Koizuka I; Jia XS; Kirihata M; Tsukuma H; Aozasa K
    Int J Cancer; 2007 Jan; 120(2):406-10. PubMed ID: 17066445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene mutation analysis of sinonasal lymphomas in Indonesia.
    Kurniawan AN; Hongyo T; Hardjolukito ES; Ham MF; Takakuwa T; Kodariah R; Hoshida Y; Nomura T; Aozasa K
    Oncol Rep; 2006 May; 15(5):1257-63. PubMed ID: 16596195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
    Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
    Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal and nasal-type natural killer (NK)/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association.
    Peh SC; Quen QW
    Med J Malaysia; 2003 Jun; 58(2):196-204. PubMed ID: 14569739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nasal natural killer/T-cell lymphoma genes].
    Li JM; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):308-10. PubMed ID: 16181557
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.